As of November 14, 2026, Surrozen, Inc./DE has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on January 30, 2026 (Form 8-K, January 30, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Surrozen, Inc./DE? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Surrozen, Inc./DE reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-01-30. Every row below is cited to the filing it comes from, and this page adds each new change as Surrozen, Inc./DE files it.
Also on the record for Surrozen, Inc./DE
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G/A, by Millennium Management LLC | 3.2% of the class | 5%+ stakes | Source |
| November 6, 2026 | Stake report, Schedule 13D/A, by The Column Group III GP, LP | 21.4% of the class | 5%+ stakes | Source |
| October 22, 2026 | Stake report, Schedule 13D/A, by The Column Group III GP, LP | 21.5% of the class | 5%+ stakes | Source |
| October 7, 2026 | Stake report, Schedule 13G/A, by Boxer Capital Management, LLC | 11.6% of the class | 5%+ stakes | Source |
| October 1, 2026 | Stake report, Schedule 13G, by Commodore Capital LP | 7.5% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by StemPoint Capital LP | 5% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Boxer Capital Management, LLC | 8.9% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by BRAIDWELL LP | 3.9% of the class | 5%+ stakes | Source |
| August 11, 2026 | Stake report, Schedule 13G/A, by 5AM Partners VII, LLC | 7.8% of the class | 5%+ stakes | Source |
| July 24, 2026 | Stake report, Schedule 13G/A, by Chen Yu | 9.9% of the class | 5%+ stakes | Source |
| May 18, 2026 | Stake report, Schedule 13D/A, by The Column Group III GP, LP | 29.3% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by Boxer Capital Management, LLC | 6.67% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Surrozen, Inc./DE now and the warning signs.
Free to see. No signup.
Keep reading
More on Surrozen, Inc./DE and the records around it.
Surrozen, Inc./DE elsewhere on the record
- 5%+ stake filings Nov 2026
- Form D filing Apr 2025
- Who owns it
Companies that share a holder
- 5AM Partners VII, LLC also filed stake reports on 1 other company: SKYE BIOSCIENCE, INC. (Sep 2026)
- Boxer Capital Management, LLC also filed stake reports on 1 other company: Q32 Bio Inc. (Nov 2026)
- BRAIDWELL LP also filed stake reports on 1 other company: Amanat Acquisition Corp. (Aug 2026)
Watch Surrozen, Inc./DE
Get an email when Surrozen, Inc./DE files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Surrozen, Inc./DE?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Surrozen, Inc./DE: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Surrozen, Inc./DE covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 31 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-01-30 | Reported | not named in the filing | 8-K, 2026-01-30 |
New leaders reset buying decisions — get the Full Report on Surrozen, Inc./DE: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Surrozen, Inc./DE, with the record behind each one.
Find candidates like senior executive at Surrozen, Inc./DEEvery change, in the filing's words
Reported
(b) Resignation of Director On January 26, 2026, Shao-Lee Lin, M.D., Ph.D. resigned from the Board of Directors of Surrozen, Inc., or the Company, effective immediately.
- Dr. Lin's resignation was not because of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- The Company thanks Dr. Lin for her service and dedication to the Company's mission.
Tools for this story
Each opens in a new tab, filled in for Surrozen, Inc./DE. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
